In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Radiosurgery New York (RSNY) Demystifies Kinds of Prostate Cancer for Enhanced Patient Awareness NEW YORK, NY, USA, August 24, 2023/EINPresswire.com/ -- Radiosurgery ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants published by Wiley online in CANCER, investigators found ...

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...

Many clinicians who treat men with prostate cancer may be unfamiliar with the term "treatment-emergent small-cell neuroendocrine prostate cancer" (t-SCNC). That's because it has been considered a rare ...